Staar Surgical Co header image

Staar Surgical Co

STAA

Equity

ISIN null / Valor 972813

NASDAQ (2026-10-08)
USD 22.38+0.09%

Staar Surgical Co
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

STAAR Surgical Company is a U.S.-based medical device firm that develops, manufactures and sells implantable phakic intraocular lenses — most notably the Visian/EVO line of implantable collamer lenses — used by ophthalmic surgeons to correct refractive errors such as myopia and astigmatism. The company markets its proprietary Collamer lens material and related surgical instruments to clinics and distributors around the world, relying on regulatory approvals and clinical data to support adoption in key markets. As a publicly traded company, STAAR generates revenue primarily from lens sales and aftermarket services and continues to invest in product development and surgeon training to expand the clinical applications and geographic reach of its vision-correction technologies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-15.5%1Y
-41.9%3Y
-80.7%5Y

Performance

56.5%1Y
62.1%3Y
61.0%5Y

Volatility

Market cap

1122 M

Market cap (USD)

Daily traded volume (Shares)

639,652

Daily traded volume (Shares)

1 day high/low

24.23 / 23.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
17.46%USD 119.47
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.01%USD 28.06
Harrow Inc
Harrow Inc Harrow Inc Valor: 45675535
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%USD 30.52
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.37%USD 387.12
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 16.37
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 7.96
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 34.83
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 36.16
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.83%USD 25.82
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.42%USD 1.18